Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
News & Press: Breaking News

Reuters Article: FDA Plans New Compounding Pharmacy Policy, Agency Head Says

Monday, September 18, 2017   (0 Comments)
Posted by: Dagmar Anderson
Share |
BOSTON (Reuters) - The head of the U.S. Food and Drug Administration said on Friday the agency is working on a new policy that would encourage more compounding pharmacies to register under a law enacted in the wake of a deadly 2012 meningitis outbreak linked to one such company.

FDA Commissioner Scott Gottlieb made the comments in an interview with Reuters as federal prosecutors in Boston prepare for the second criminal trial over contaminated steroids manufactured by the now-defunct New England Compounding Center (NECC).

Article here.

Association Management Software Powered by YourMembership  ::  Legal